Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline RecommendationsN Lynn Henry, Mark R Somerfield, Vandana G Abramson, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
JAMA Network Open|November 11, 2022
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical TrialDawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
Translational Behavioral Medicine|April 16, 2026
Evaluating an online-delivered resistance exercise intervention for racially diverse breast cancer survivors using the RE-AIM frameworkIsabel L Wakefield, Océane Streubel, Adana A M Llanos, et al.
JCO Clinical Cancer Informatics|April 4, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization ToolGillian Gresham, Michael Luu, N Lynn Henry, et al.
Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|April 29, 2017
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitorsKunal C Kadakia, Kelley M Kidwell, Nicholas J Seewald, et al.
Cancer|March 13, 2019
Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202N Lynn Henry, Joseph M Unger, Cathee Till, et al.
Pageof 19